A multi-disciplinary team identifies new ways to classify glioblastoma patients and points to new therapies
A consortium led by Dr Carmen Balaña of the Badalona Applied Research Group in Oncology (B-ARGO Group) of the Catalan Institute of Oncology (ICO) Badalona at the Germans Trias i Pujol Research Institute (IGTP) has published two papers that indicate better ways to stratify glioblastoma patients, which could allow doctors to make predictions about prognosis and make better decisions about which treatments to apply.